NCT02730689View on ClinicalTrials.gov

A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone

PHASE1CompletedINTERVENTIONAL

Enrollment

66

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions

Healthy Volunteers

Interventions

DRUG

DP-R207

DRUG

Rosuvastatin

DRUG

Ezetimibe

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Alvogen Korea

INDUSTRY

NCT02730689 - A Study to Compare the Pharmacokinetics of DP-R207 in Comparison to Each Component Administered Alone | Biotech Hunter | Biotech Hunter